Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
BMU107 Naringenin Attenuates Ox-LDL-induced Injury in HUVECs by Regulating Lipophagy Partly through the SOCE Pathway.(BMU107-2.800) 2.800 Current Pharmaceutical Design
BMU109 Banana starch nanoparticles disrupt the integrity of the intestinal barrier by opening tight junctions in mice.(BMU109-12.100) 12.100  Small 
BMU111 Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2.(BMU111-15.000) 15.000 Bone Research 
BMU111 Alpha‐Lipoic Acid Alleviates Isoflurane‐Induced Cognitive Dysfunction in Juvenile Mice by Activating Peroxisome Proliferator Activated Receptor Gamma Coactivator‐1 Alpha.(BMU111-6.900) 6.900 Food Frontiers 
BMU111 NUMB endocytic adaptor protein (NUMB) mediates the anti-hepatic fibrosis effect of artesunate (ART) by inducing senescence in hepatic stellate cells (HSCs).(BMU111-4.900) 4.900 Chinese Journal of Natural Medicines 
BMU111 Encapsulated benzoic acid alleviated LPS-induced intestinal damage via NRF2 activation.(BMU111-5.900) 5.900  Food Bioscience 
BMU111 EGR1‐Driven Re‐Epithelialization Enabled by Rutin‐Based Self‐Assembled Hydrogel Platform for Oral Ulcer Therapy.(BMU111-9.600) 9.600 Advanced Healthcare Materials 
KTA0004 Annexin V-AbFluor™ 647 Apoptosis Detection kit (Red Fluorescence) CYP2J2-derived epoxyeicosatrienoic acids protect against doxorubicin-induced cardiotoxicity by reducing oxidative stress and apoptosis via activation of the AMPK pathway.(KTA0004-3.4) 3.4 Heliyon
KTA0004 Annexin V-AbFluor™ 647 Apoptosis Detection kit (Red Fluorescence) Protective mechanism of Prim-O-glucosylcimifugin in the treatment of osteoarthritis: Based on lncRNA XIST regulation of Nav1. 7.(KTA0004-6.9) 6.9 Biomedicine & Pharmacotherapy
KTA0004 Annexin V-AbFluor™ 647 Apoptosis Detection kit (Red Fluorescence) Gastrodin Alleviates Angiotensin II-Induced Hypertension and Myocardial Apoptosis via Inhibition of the PRDX2/p53 Pathway In Vivo and In Vitro.(KTA0004-4.3) 4.3 Pharmaceuticals